Baseline insomnia severity modifies the association between sleep efficiency and next-day daytime HRV (RMSSD) in a predominantly healthy cohort
In a wearable-based dataset of 49 participants over 4 weeks, the interaction between CSD-style sleep efficiency and baseline Insomnia Severity Index (ISI) was positively associated with next-day daytime RMSSD (β=0.0060; 95% CI, 0.0023 to 0.0097; P=0.002). This suggests that individuals with higher baseline insomnia symptoms show a stronger positive coupling between sleep efficiency and next-day heart rate variability.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Baseline insomnia severity modifies the association between sleep efficiency and next-day daytime HRV (RMSSD) in a predominantly healthy cohort The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).
The Claim
Baseline insomnia severity modifies the association between sleep efficiency and next-day daytime HRV (RMSSD) in a predominantly healthy cohort
This conclusion is most relevant to: 49 participants from a publicly available wearable dataset, predominantly healthy with non-severe baseline insomnia symptoms (no participant met criteria for severe baseline insomnia).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Insomnia severity modifies diary-based sleep-continuity and sleep-initiation associations with next-day daytime HRV in a real-world wearable dataset. (Digital health, 2026) —
How It Works
The proposed biological pathway:
- ▸Baseline insomnia severity is measured using the Insomnia Severity Index
- ▸Daily sleep efficiency is derived from Consensus Sleep Diary-style definitions
- ▸Daytime HRV (RMSSD) is aggregated from 5-minute windows between 09:00 and 23:00
- ▸Higher baseline ISI modifies the positive association between sleep efficiency and next-day RMSSD
Who Might Benefit
Evidence fit by population:
- ▸49 participants from a publicly available wearable dataset, predominantly healthy with non-severe baseline insomnia symptoms (no participant met criteria for severe baseline insomnia)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Higher-ISI estimates were based on few participants in the moderate-ISI range and on person-days meeting daytime HRV coverage criteria
- ▸Findings should not be extrapolated to populations with severe or clinically diagnosed insomnia
- ▸Secondary analysis of a publicly available dataset with potential selection bias
Frequently Asked Questions
What is the primary finding of this study?▼
The study found that baseline insomnia severity modifies the association between sleep efficiency and next-day daytime heart rate variability (RMSSD), with a positive interaction (β=0.0060).
How was sleep efficiency measured?▼
Sleep efficiency was operationalized using a Consensus Sleep Diary (CSD)-style definition that explicitly incorporated wake after sleep onset (WASO).
What population was studied?▼
The study included 49 participants from a publicly available wearable dataset, with predominantly non-severe baseline insomnia symptoms; no participant had severe baseline insomnia.
What were the key limitations of the study?▼
Key limitations include small sample size for higher-ISI estimates, reliance on person-days meeting HRV coverage criteria, and inability to generalize to severe or clinically diagnosed insomnia populations.
References
- 1.Meng X, Cai M. “Insomnia severity modifies diary-based sleep-continuity and sleep-initiation associations with next-day daytime HRV in a real-world wearable dataset..” Digital health, 2026. PMID: 42460158 DOI: 10.1177/20552076261469378